Medpace Holdings, Inc.MEDPNASDAQ
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank92
3Y CAGR+9.4%
5Y CAGR+4.0%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
+9.4%/yr
vs +15.1%/yr prior
5Y CAGR
+4.0%/yr
Recent acceleration
Acceleration
-5.7pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
20256.31+36.2%
20244.63-6.3%
20234.94+2.4%
20224.82-26.3%
20216.54+26.3%
20205.18+52.3%
20193.40+23.7%
20182.75-25.5%
20173.69+10.2%
20163.35-